Poluéktov L V, Reĭs B A, Red'kin Iu V, Konvaĭ V D, Ktenidi L I, Sen'ko V P
Anesteziol Reanimatol. 1990 Sep-Oct(5):48-51.
The dynamic study of a number of clinical and laboratory findings in 107 patients with acute peritonitis have shown that with the current complex infusion therapy the onset of postoperative complications is to a great extent mediated by high toxin level--medium molecular mass polypeptide, inhibiting the processes of protein synthesis and consequently causing changes in the relationship between adaptation compensatory reactions, which demonstrates the necessity of additional active detoxicating therapy, i.e. hemosorption (HS). HS was performed to 126 patients and its efficacy in pronounced toxemia was established. The data obtained make it possible to consider HS as an effective means preventing the onset of postoperative complications in acute peritonitis.
对107例急性腹膜炎患者的多项临床和实验室检查结果进行的动态研究表明,在当前的综合输液治疗中,术后并发症的发生在很大程度上是由高毒素水平——中分子质量多肽介导的,它抑制蛋白质合成过程,从而导致适应代偿反应之间的关系发生变化,这表明有必要进行额外的积极解毒治疗,即血液吸附(HS)。对126例患者进行了血液吸附,并确定了其在明显毒血症中的疗效。所获得的数据使人们有可能将血液吸附视为预防急性腹膜炎术后并发症发生的有效手段。